Buy, Sell Or Hold Mesoblast Ltd ADR (NASDAQ:MESO) At $14.97?

In recent trading session, Mesoblast Ltd ADR (NASDAQ:MESO) saw 0.74 million shares changing hands at last check today with its beta currently measuring 2.39. Company’s recent per share price level of $14.97 trading at $2.63 or 21.31% at last check today assigns it a market valuation of $1.91B. That most recent trading price of MESO’s stock is at a discount of -46.96% from its 52-week high price of $22.00 and is indicating a premium of 61.39% from its 52-week low price of $5.78. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.23 million shares which gives us an average trading volume of 209.38K if we extend that period to 3-months.

For Mesoblast Ltd ADR (MESO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 10 analysts covering the stock, 2 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Mesoblast Ltd ADR (NASDAQ:MESO) trade information

Mesoblast Ltd ADR’s shares saw a change of 85.96% in year-to-date performance and have moved 34.74% in past 5-day. Mesoblast Ltd ADR (NASDAQ:MESO) showed a performance of 27.19% in past 30-days. Number of shares sold short was 2.69 million shares which calculate 11.31 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 11.5 to the stock, which implies a fall of -30.17% to its recent value today. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would jump 26.52% in reaching the projected high whereas dropping to the targeted low would mean a gain of 26.52% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.34% during past 5 years.

Mesoblast Ltd ADR (NASDAQ:MESO)’s Major holders

Insiders are in possession of 0.06% of company’s total shares while institution are holding 3.11 percent of that, with stock having share float percentage of 3.11%. Investors also watch the number of corporate investors in a company very closely, which is 3.11% institutions for Mesoblast Ltd ADR that are currently holding shares of the company. MORGAN STANLEY is the top institutional holder at MESO for having 83617.0 shares of worth $0.57 million. And as of 2024-06-30, it was holding 0.0847 of the company’s outstanding shares.

The second largest institutional holder is GROUP ONE TRADING, L.P., which was holding about 0.23 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.0231 of outstanding shares, having a total worth of $1.55 million.

On the other hand, iShares Trust-iShares Biotechnology ETF and Trust for Professional Managers-ActivePassive International Equity ETF are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 523.48 shares of worth $7.93 million or 0.41% of the total outstanding shares. The later fund manager was in possession of 8.48 shares on Feb 28, 2025 , making its stake of worth around $0.13 million in the company or a holder of 0.01% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.